Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPH Receptor A2 anticorps

EPHA2 Reactivité: Humain WB, ELISA, IHC Hôte: Souris Monoclonal 1B3C7 unconjugated
N° du produit ABIN1724651
  • Antigène Voir toutes EPH Receptor A2 (EPHA2) Anticorps
    EPH Receptor A2 (EPHA2)
    Reactivité
    • 168
    • 127
    • 69
    • 14
    • 6
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 177
    • 19
    • 4
    • 1
    Souris
    Clonalité
    • 175
    • 25
    • 1
    Monoclonal
    Conjugué
    • 69
    • 18
    • 10
    • 10
    • 10
    • 10
    • 10
    • 10
    • 9
    • 8
    • 8
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp EPH Receptor A2 est non-conjugé
    Application
    • 117
    • 68
    • 27
    • 23
    • 15
    • 14
    • 13
    • 7
    • 7
    • 7
    • 7
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
    Fonction
    EphA2 Antibody
    Purification
    Ascitic fluid
    Immunogène
    Purified recombinant fragment of EphA2 expressed in E. Coli.
    Clone
    1B3C7
    Isotype
    IgM
    Top Product
    Discover our top product EPHA2 Anticorps primaire
  • Indications d'application
    ELISA: 1/10000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Abraham, Knapp, Cheng, Snyder, Mittal, Bangari, Kinch, Wu, Dhariwal, Mohammed: "Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 12, Issue 2, pp. 353-60, (2006) (PubMed).

    Landen, Kinch, Sood: "EphA2 as a target for ovarian cancer therapy." dans: Expert opinion on therapeutic targets, Vol. 9, Issue 6, pp. 1179-87, (2005) (PubMed).

  • Antigène
    EPH Receptor A2 (EPHA2)
    Autre désignation
    EphA2 (EPHA2 Produits)
    Synonymes
    anticorps ARCC2, anticorps CTPA, anticorps CTPP1, anticorps CTRCT6, anticorps ECK, anticorps epha2, anticorps MGC89505, anticorps AW545284, anticorps Eck, anticorps Myk2, anticorps Sek-2, anticorps Sek2, anticorps id:ibd5152, anticorps rtk6, anticorps G42, anticorps XE10, anticorps epha2-A, anticorps EPH receptor A2, anticorps Eph receptor A2, anticorps epoxide hydrolase, anticorps eph receptor A2 a, anticorps EPH receptor A2 L homeolog, anticorps EPHA2, anticorps Epha2, anticorps epha2, anticorps ephA2, anticorps epha2a, anticorps epha2.L
    Sujet

    Description: EPH receptor A2 (EphA2), with 976-amino acid protein (about 107 kDa), belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EphA1, EphA2, EphA3, EphA4, EphA5, EphA6, EphA7, EphA8, EphA10, EphB1, EphB2, EphB3, EphB4 and EphB6 are Eph family receptors for Ephrin family ligands. In normal cells, EphA2 negatively regulates cell growth and invasiveness. EphA2 is overexpressed by many human cancers, and is often associated with poor prognostic features. The clinical significance of the expression of EphA2 was observed in breast, prostate, colon, skin, cervical, ovarian, and lung cancers.EphA2 may serve as a novel target for bladder cancer, colonic adenocarcinoma and ovarian cancer therapy.

    Aliases: ECK, EPHA2

    ID gène
    1969
    HGNC
    1969
    UniProt
    P29317
    Pathways
    Signalisation RTK
Vous êtes ici:
Support technique